Susan Hasty, Publisher
Table of Contents . . . March 15th, 1999Non-Subscriber - Summaries Only
Therapy (TB) - Rifampin Monoresistance Characterized
Observed Therapy - Medication Monitors May Enhance Selective DOT
Pathogenesis - Antioxidant Defenses Against Tuberculosis Examined
Testing (TB) - PCR Has Limited Value in Children
Therapy (TB) - C-8 Methoxy Group May Improve Quinolone Efficacy
Therapy (TB) - Treatment Programs Can Work in Poor Areas
Unusual Presentation - TB Presenting as Respiratory Failure Examined
Influenza Vaccines - Middle-Aged Women with Chronic Conditions at Higher Risk During Flu Season
Influenza Vaccines - Vaccine Reduces Flu Incidence in Health Care Workers
Streptococcus A (Outbreak) - Three Strains Involved in Strep Cases
DNA Vaccines (TB) - "A Genetic Vaccine for M. tuberculosis."
Immunology (TB) - "Human T Cell Responses to Mycobacterium tuberculosis."
Opportunistic Infections - "Continuing Study on AIDS Related Opportunistic Pathogens."
Chemotherapy (Animal Studies) - "Moxifloxacin (BAY12-8039), A New 8-Methoxyquinolone, Is Active in a Mouse Model of Tuberculosis."
Meningococcal Disease - "Recent Emergence of Serogroup C Meningococcal Disease in Greece."
Mycobacterial Infection (Chemotherapy) - "Exposure to Antibiotics Induces Expression of the Mycobacterium tuberculosis sigF Gene: Implications for Chemotherapy Against Mycobacterial Persistors."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.